Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers
about
Nrf2: a potential therapeutic target for diabetic neuropathy.Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.Targeting NRF2 for Improved Skin Barrier Function and Photoprotection: Focus on the Achiote-Derived Apocarotenoid Bixin.RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene.
P2860
Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Topical application of RTA 408 ...... ed by healthy human volunteers
@ast
Topical application of RTA 408 ...... ed by healthy human volunteers
@en
type
label
Topical application of RTA 408 ...... ed by healthy human volunteers
@ast
Topical application of RTA 408 ...... ed by healthy human volunteers
@en
prefLabel
Topical application of RTA 408 ...... ed by healthy human volunteers
@ast
Topical application of RTA 408 ...... ed by healthy human volunteers
@en
P2093
P2860
P1433
P1476
Topical application of RTA 408 ...... ed by healthy human volunteers
@en
P2093
Angela R Goldsberry
Chun-Yue I Lee
Colin J Meyer
Joel W Proksch
Keith W Ward
Megan L O'Grady
Scott A Reisman
P2860
P2888
P356
10.1186/S12895-015-0029-7
P577
2015-07-14T00:00:00Z
P5875
P6179
1037945096